Found: 13
Select item for more details and to access through your institution.
Natural Products in the Pharmaceutical Industry.
- Published in:
- BioScience, 1966, v. 16, n. 10, p. 706, doi. 10.2307/1293734
- By:
- Publication type:
- Article
The MMSE should not be the sole indicator of fitness to drive in mild Alzheimer’s dementia.
- Published in:
- Acta Neurologica Belgica, 2018, v. 118, n. 4, p. 637, doi. 10.1007/s13760-018-1036-3
- By:
- Publication type:
- Article
Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12336-0
- By:
- Publication type:
- Article
Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
- Published in:
- Human Reproduction, 2009, v. 24, n. 8, p. 2014, doi. 10.1093/humrep/dep113
- By:
- Publication type:
- Article
Long-Term Survival in Patients With Advanced Melanoma.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
- By:
- Publication type:
- Article
Health-state utilities in long-term advanced melanoma survivors comparable with the general population.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 9, p. 2517, doi. 10.1007/s11136-023-03427-9
- By:
- Publication type:
- Article
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 1, p. 69, doi. 10.1080/0284186X.2020.1818823
- By:
- Publication type:
- Article
Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 4, p. 1653, doi. 10.1210/jc.2002-021585
- By:
- Publication type:
- Article
Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 4, p. 1653, doi. 10.1210/jc.2002-021585
- By:
- Publication type:
- Article
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 15, doi. 10.1111/pcmr.13117
- By:
- Publication type:
- Article
Modification of poly(acrylic acid) via reaction with group IVA reactants.
- Published in:
- Journal of Applied Polymer Science, 1972, v. 16, n. 7, p. 1851, doi. 10.1002/app.1972.070160721
- By:
- Publication type:
- Article
Survival of stage IV melanoma in Belgium and the Netherlands.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 2, p. e118, doi. 10.1111/jdv.17668
- By:
- Publication type:
- Article